September 2011 PMID 21868780

Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies.

Jia-Yi Dong, Pengcheng Xun, Ka He, Li-Qiang Qin

Download social card

Mentions

Peak: 9 in Oct 2021

across 5 sources since Oct 2021

Extended reach

38,943

potential audience

Total likes

591

Video views

10,815

Mentions per month

Oct 2021 – Jan 2026

Where it's discussed

X / Twitter14 posts
Facebook8 posts
News5 articles
Blogs4 articles
YouTube2 videos

AI synopsis

What people are saying

The overall tone reflects mild curiosity about the research's implications, such as mentions of dietary choices and supplement intake, with phrases like "pay attention" and "considering magnesium intake," suggesting some interest but not comprehensive engagement. The absence of detailed critique or call to action indicates a moderate level of relevance and impact.

AgreementNeither agree nor disagree

The posts don't strongly support or oppose the findings, showing neutrality or mixed reactions.

InterestModerate interest

There is a slight interest in the topic, especially regarding the practical implications like diet and supplement intake.

EngagementModerate engagement

Posts attempt to discuss the publication and its relevance, but do not deeply analyze the research or its methodology.

ImpactNeutral impact

The discussions seem limited in scope, reflecting some curiosity but unlikely to cause broad behavioral change or policy impact.

Abstract in brief

A meta-analysis of 13 prospective studies involving over 500,000 people found that higher magnesium intake is linked to a lower risk of developing type 2 diabetes, with each 100 mg/day increase in magnesium reducing the risk by about 14%.
The inverse relationship was consistent across different groups, like different regions and follow-up durations, but it was more noticeable in overweight individuals (BMI 25 or higher).
The findings suggest that increasing magnesium intake could be a useful strategy for reducing diabetes risk, and the relationship appears to be dose-dependent, meaning more magnesium leads to a greater reduction in risk.]

Read the full abstract